Therapeutic cannabis: market revenue Latin America 2016-2028

The revenue of the therapeutic cannabis segment of the cannabis market in Latin America was forecast to continuously increase between 2024 and 2028 by in total 998.3 million U.S. dollars (+76.1 percent). After the twelfth consecutive increasing year, the indicator is estimated to reach 2.3 billion U.S. dollars and therefore a new peak in 2028. Notably, the revenue of the therapeutic cannabis market was continuously increasing over the past years.

Revenue of the therapeutic cannabis market in Latin America from 2016 to 2028 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

The therapeutic cannabis market covers cannabinoid-based therapeutic products with low tetrahydrocannabinol (THC) levels. These products are used for medicinal purposes and are intended to improve the quality of life, e.g., by reducing stress and/or anxiety. Prescribed and non-prescribed products are included in our scope and can be consumed through oils, capsules, topicals, e-liquid, edibles, and flowers.

Citation formats